Expression of mTOR pathway proteins in human amniotic fluid stem cells

International Journal of Molecular Medicine

Volumn 23, Issue 6, 2009, Pages 779-784

  Siegel, Nicol ^a   Valli, Alessandro ^a   Fuchs, Christiane ^a   Rosner, Margit ^a   Hengstschläger, Markus ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Akt; Amniotic fluid; mTOR; p70S6K; raptor; Rictor; Stem cell; Tuberin

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; PROTEIN KINASE B; PROTEIN MLST8; PROTEIN P70S6K; RAPTOR PROTEIN; RICTOR PROTEIN; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INTERACTING PROTEIN; TRANSCRIPTION FACTOR; TUBERIN; UNCLASSIFIED DRUG;

AMNIOTIC FLUID CELL; AMNIOTIC FLUID STEM CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMNIOTIC FLUID; CARRIER PROTEINS; CELLS, CULTURED; HUMANS; IMMUNOBLOTTING; IMMUNOSUPPRESSIVE AGENTS; PHOSPHORYLATION; PROTEIN KINASES; PROTEINS; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION; SIROLIMUS; STEM CELLS; TUMOR SUPPRESSOR PROTEINS;

EID: 67649547005     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000192     Document Type: Article

References (33)

1. Rosenthal N: Prometheus's vulture and the stem-cell promise. N Engl J Med 349: 267-274, 2003.
2. Cedar SH, Cooke JA, Luo Z, et al: From embryos to embryonic stem cells: biopolitics and therapeutical potential. Reprod Biomed Online 13: 725-731, 2006.
3. Pennings G: The ethics of using embryos in research. Reprod Biomed Online 14: 92-97, 2007.
4. Schulman A: The search for alternative sources of human pluripotent stem cells. Stem Cell Rev 1: 291-292, 2005.
5. Edwards RG and Hollands P: Will stem cells in cord blood, amniotic fluid, bone marrow and peripheral blood soon be unnecessary in transplantation? Reprod Biomed Online 14: 396-401, 2007.
6. Dimos JT, Rodolfa KT, Niakan KK, et al: Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321: 1218-1221, 2008.
7. Park I-H, Arora N, Huo H, et al: Disease-specific induced pluripotent stem cells. Cell 134: 877-886, 2008.
8. Maherali N and Hochedlinger K: Induced pluripotency of mouse and human somatic cells. Cold Spring Harb Symp Quant Biol [Epub ahead of print], 2008.
9. Prusa AR, Marton E, Rosner M, et al: Oct4 expressing cells in human amniotic fluid: a new source for stem cell research? Hum Reprod 18: 1489-1493, 2003.
10. Siegel N, Rosner M, Hanneder M, et al: Stem cells in amniotic fluid as new tools to study human genetic diseases. Stem Cell Rev 3: 256-264, 2007.
11. Simantov R: Amniotic stem cell international. Reprod Biomed Online 16: 597-598, 2008.
12. Aboushwareb T and Atala A: Stem cells in urology. Nat Clin Pract Urol 5: 621-631, 2008.
13. In t'Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al: Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 102: 1548-1549, 2003.
14. Prusa AR, Marton E, Rosner M, et al: Neurogenic cells in human amniotic fluid. Am J Obstet Gynecol 191: 309-314, 2004.
15. Tsai M-S, Lee J-L, Chang Y-J, et al: Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod 19: 1450-1456, 2004.
16. Karlmark KR, Freilinger A, Marton E, et al: Activation of ectopic Oct4 and Rex-1 promoters in human amniotic fluid cells. Int J Mol Med 16: 987-992, 2005.
17. Bossolasco P, Montemurro T, Cova L, et al: Molecular and phenotypic characterization of human amniotic fluid cells and their differentiation potential. Cell Res 16: 329-336, 2006.
18. De Coppi P, Bartsch G, Siddiqui MM, et al: Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25: 100-106, 2007.
19. Perin L, Giuliani S, Jin D, et al: Renal differentiation of amniotic fluid stem cells. Cell Prolif 40: 936-948, 2007.
20. Murray P, Camussi G, Davies J, et al: The KIDSTEM European research training network. Developing a stem cell based therapy to replace nephrons lost through reflux nephropathy. Organogenesis 3: 1-4, 2007.
21. Perin L, Giuliani S, Sedrakyan S, et al: Stem cell and regenerative science applications in the development of bioengineering of renal tissue. Pediatr Res 63: 467-471, 2008.
22. Yang Q and Guan K-L: Expanding mTOR signaling. Cell Res 17: 666-681, 2007.
23. Dann SG, Selvaraj A, Thomas G, et al: mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. Trends Mol Med 13: 252-259, 2007.
24. Bhaskar PT and Hay N: The two TORCs and Akt. Dev Cell 12: 487-502, 2007.
25. Wullschleger S, Loewith R, Hall MN, et al: TOR signaling in growth and metabolism. Cell 124: 471-484, 2006.
26. Guertin DA and Sabatini DM: Defining the role of mTOR in cancer. Cancer Cell 12: 9-22, 2007.
27. Rosner M, Hanneder M, Siegel N, et al: The mTOR pathway and its role in human genetic diseases. Mutat Res 659: 284-292, 2008.
28. Chiang GG and Abraham RT: Targeting the mTOR signaling network in cancer. Trends Mol Med 13: 433-442, 2007.
29. Hengstschläger M, Prusa A, Repa C, et al: Subtelomeric rearrangements as neutral genomic polymorphisms. Am J Med Genet 133: 48-52, 2005.
30. Rosner M and Hengstschläger M: Cytoplasmic and nuclear distribution of the protein complexes mTORC1 and mTORC2: rapamycin triggers dephosphorylation and delocalization of the mTORC2 components rictor and sin1. Hum Mol Genet 17: 2934-2948, 2008.
31. Rosner M, Hofer K, Kubista M, et al: Cell size regulation by the human TSC tumor suppressor proteins depends on PI3K and FKBP38. Oncogene 22: 4786-4798, 2003.
32. Rosner M, Freilinger A, Hanneder M, et al: p27 localization depends on the tumor suppressor protein tuberin. Hum Mol Genet 16: 1541-1556, 2007.
33. Sarbassov DD, Ali SM, Sengupta S, et al: Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell 22: 159-168, 2006.